ExploreWatchlistsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Operating expenses

ROHTO PHARMACEUTICAL CO.,LTD. (4527)

Market cap
¥565.1B
P/E ratio
16.4x
Rohto Pharmaceutical manufactures and sells eye care, skin care, and oral medications globally through its subsidiaries including Mentholatum brands.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndOperating expenses (Million JPY)YoY (%)
Mar 31, 2025135,999+16.00%
Mar 31, 2024117,237+13.32%
Mar 31, 2023103,461+18.73%
Mar 31, 202287,139+4.06%
Mar 31, 202183,736-8.14%
Mar 31, 202091,154+2.64%
Mar 31, 201988,812+8.36%
Mar 31, 201881,962+8.00%
Mar 31, 201775,893-9.16%
Mar 31, 201683,543+7.88%
Mar 31, 201577,440

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat